Evidence map›Paper›PMID 32350257›Full record

ArticleNature communications2020

LSD1-mediated enhancer silencing attenuates retinoic acid signalling during pancreatic endocrine cell development.

Nicholas K Vinckier, Nisha A Patel, Ryan J Geusz, Allen Wang, Jinzhao Wang, Ileana Matta, Austin R Harrington, Matthew Wortham, Nichole Wetton, Jianxun Wang and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Epigenetic Regulation of Pancreas Development and Function.Advances in anatomy, embryology, and cell biology · 2024
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Tbx5 driveseLife · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Nicholas K Vinckier *Departments of Pediatrics and Cellular & Molecular Medicine, Pediatric Diabetes Research Center, Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA, 92093, USA.
Nisha A Patel *Departments of Pediatrics and Cellular & Molecular Medicine, Pediatric Diabetes Research Center, Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA, 92093, USA.
Ryan J Geusz *Departments of Pediatrics and Cellular & Molecular Medicine, Pediatric Diabetes Research Center, Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA, 92093, USA.ORCID http://orcid.org/0000-0002-4897-9305
Allen WangDepartments of Pediatrics and Cellular & Molecular Medicine, Pediatric Diabetes Research Center, Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA, 92093, USA.
Jinzhao WangDepartments of Pediatrics and Cellular & Molecular Medicine, Pediatric Diabetes Research Center, Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA, 92093, USA.ORCID http://orcid.org/0000-0003-1595-9460
Ileana MattaDepartments of Pediatrics and Cellular & Molecular Medicine, Pediatric Diabetes Research Center, Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA, 92093, USA.
Austin R HarringtonDepartments of Pediatrics and Cellular & Molecular Medicine, Pediatric Diabetes Research Center, Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA, 92093, USA.
Matthew WorthamDepartments of Pediatrics and Cellular & Molecular Medicine, Pediatric Diabetes Research Center, Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA, 92093, USA.
Nichole WettonDepartments of Pediatrics and Cellular & Molecular Medicine, Pediatric Diabetes Research Center, Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA, 92093, USA.
Jianxun WangHoward Hughes Medical Institute and Department of Medicine, University of California, San Diego, La Jolla, CA, 92093, USA.
Ulupi S JhalaDepartment of Pediatrics and Pediatric Diabetes Research Center, University of California, San Diego, La Jolla, CA, 92093, USA.
Michael G RosenfeldHoward Hughes Medical Institute and Department of Medicine, University of California, San Diego, La Jolla, CA, 92093, USA.ORCID http://orcid.org/0000-0002-1572-156X
Christopher W BennerDepartment of Cellular & Molecular Medicine, University of California, San Diego, La Jolla, CA, 92093, USA.ORCID http://orcid.org/0000-0002-4618-0719
Hung-Ping ShihDepartment of Translational Research & Cellular Therapeutics, Diabetes & Metabolism Research Institute, City of Hope, Duarte, CA, 91010, USA.ORCID http://orcid.org/0000-0003-3035-5841
Maike SanderDepartments of Pediatrics and Cellular & Molecular Medicine, Pediatric Diabetes Research Center, Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA, 92093, USA. masander@ucsd.edu.ORCID http://orcid.org/0000-0001-5308-7785
University of California San Diego · USHoward Hughes Medical Institute · USCity of Hope · US

Funding

Training Program in Basic Clinical GeneticsT32GM008666 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HAMILTON, BRUCE A · 1998 to 2021
$8.6M
Nkx6 gene function in pancreas developmentR01DK068471 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI WORTHAM, MATTHEW · 2004 to 2024
$6.6M
Predoctoral and Postdoctoral Training in Cancer Cell BiologyT32CA067754 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JEAN Y.J. WANG · 1995 to 2026
$6.5M
Epigenetic strategies for the in vitro generation of replacement beta cellsU01DK089567 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SANDER, MAIKE · 2010 to 2013
$4.7M
Genetic Regulation of Adiposity and Associated CVD RisksR01DK064391 · NIDDK · WRIGHT STATE UNIVERSITY · PI TOWNE, BRADFORD · 2003 to 2007
$2.7M
UC San Diego Genetics Training ProgramT32GM145427 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BRUCE A HAMILTON · 2022 to 2026
$2.6M
Microenvironmental cues control pancreas cell fate and beta-cell maturationR01DK119590 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI SHIH, HUNG-PING · 2018 to 2022
$2.1M
Signaling Cascades in Regulation of Pancreatic Beta cell mass.R01DK080147 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JHALA, ULUPI S · 2008 to 2012
$1.7M
Mechanisms of Pancreatic Beta Cell DysfunctionR01DK116038 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JHALA, ULUPI S · 2018 to 2021
$1.5M
Molecular Mechanisms Regulating Beta Cell DeathR56DK105443 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JHALA, ULUPI S · 2015 to 2016
$310k
NCI NIH HHS T32 CA067754NIDDK NIH HHS R01 DK064391NIDDK NIH HHS R01 DK068471NIDDK NIH HHS R01 DK080147NIDDK NIH HHS R01 DK116038NIDDK NIH HHS R01 DK119590NIDDK NIH HHS R56 DK105443NIDDK NIH HHS U01 DK089567NIGMS NIH HHS T32 GM008666NIGMS NIH HHS T32 GM145427
6 · The paper itself

Abstract

Developmental progression depends on temporally defined changes in gene expression mediated by transient exposure of lineage intermediates to signals in the progenitor niche. To determine whether cell-intrinsic epigenetic mechanisms contribute to signal-induced transcriptional responses, here we manipulate the signalling environment and activity of the histone demethylase LSD1 during differentiation of hESC-gut tube intermediates into pancreatic endocrine cells. We identify a transient requirement for LSD1 in endocrine cell differentiation spanning a short time-window early in pancreas development, a phenotype we reproduced in mice. Examination of enhancer and transcriptome landscapes revealed that LSD1 silences transiently active retinoic acid (RA)-induced enhancers and their target genes. Furthermore, prolonged RA exposure phenocopies LSD1 inhibition, suggesting that LSD1 regulates endocrine cell differentiation by limiting the duration of RA signalling. Our findings identify LSD1-mediated enhancer silencing as a cell-intrinsic epigenetic feedback mechanism by which the duration of the transcriptional response to a developmental signal is limited.

Indexed as

Gene SilencingSignal TransductionAdultAnimalsBase SequenceCell DifferentiationEndocrine CellsEnhancer Elements, GeneticFemaleGene Expression Regulation, DevelopmentalHistone DemethylasesHuman Embryonic Stem CellsHumansIslets of LangerhansMaleMiceHistone DemethylasesKDM1A protein, humanKDM1a protein, mouseTranscription FactorsTretinoin

Identifiers

PMID32350257
PMCPMC7190832
OpenAlexW3023229050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.